Denosumab: an antifracture therapy for postmenopausal women with osteoporosis

Menopause. 2013 Feb;20(2):117-9. doi: 10.1097/gme.0b013e31827c44bd.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bone Density / drug effects*
  • Bone Density Conservation Agents / therapeutic use*
  • Bone and Bones / physiopathology*
  • Denosumab
  • Female
  • Humans
  • Osteoporosis, Postmenopausal / drug therapy*
  • RANK Ligand / antagonists & inhibitors*
  • Radius / physiopathology*

Substances

  • Antibodies, Monoclonal, Humanized
  • Bone Density Conservation Agents
  • RANK Ligand
  • Denosumab